Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Fosun_Pharma
|
| gptkbp:CEO |
gptkb:Srinivas_Sadu
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedIn |
1978
|
| gptkbp:founder |
gptkb:P.V.N._Raju
|
| gptkbp:headquartersLocation |
gptkb:Hyderabad
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gland Pharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:ISIN |
INE068V01023
|
| gptkbp:market |
global export
|
| gptkbp:notableEvent |
IPO in 2020
|
| gptkbp:numberOfEmployees |
~4000
|
| gptkbp:parentCompany |
gptkb:Fosun_Pharma
|
| gptkbp:products |
oncology drugs
injectables ophthalmic drugs |
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:website |
https://www.glandpharma.com/
|
| gptkbp:bfsParent |
gptkb:Fosun_Pharma
|
| gptkbp:bfsLayer |
6
|